Fidelity Investments’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $103 | Sell |
51
-8,239
| -99% | -$18.5K | ﹤0.01% | 5261 |
|
|
2025
Q4 | $13.5K | Buy |
8,290
+1
| +0% | +$1 | ﹤0.01% | 4629 |
|
|
2025
Q3 | $8.79K | Hold |
8,289
| – | – | ﹤0.01% | 4642 |
|
|
2025
Q2 | $9.62K | Hold |
8,289
| – | – | ﹤0.01% | 4541 |
|
|
2025
Q1 | $7.67K | Hold |
8,289
| – | – | ﹤0.01% | 4580 |
|
|
2024
Q4 | $7.13K | Hold |
8,289
| – | – | ﹤0.01% | 4566 |
|
|
2024
Q3 | $13.8K | Hold |
8,289
| – | – | ﹤0.01% | 4329 |
|
|
2024
Q2 | $13.3K | Hold |
8,289
| – | – | ﹤0.01% | 4228 |
|
|
2024
Q1 | $19K | Hold |
8,289
| – | – | ﹤0.01% | 4039 |
|
|
2023
Q4 | $18.6K | Sell |
8,289
-3
| -0% | -$7 | ﹤0.01% | 3982 |
|
|
2023
Q3 | $25K | Buy |
8,292
+3
| +0% | +$11 | ﹤0.01% | 3694 |
|
|
2023
Q2 | $34.1K | Hold |
8,289
| – | – | ﹤0.01% | 3621 |
|
|
2023
Q1 | $31.1K | Hold |
8,289
| – | – | ﹤0.01% | 3646 |
|
|
2022
Q4 | $46.3K | Hold |
8,289
| – | – | ﹤0.01% | 3465 |
|
|
2022
Q3 | $55K | Sell |
8,289
-746
| -8% | -$6.04K | ﹤0.01% | 3453 |
|
|
2022
Q2 | $90K | Sell |
9,035
-7,134
| -44% | -$68.1K | ﹤0.01% | 3370 |
|
|
2022
Q1 | $308K | Sell |
16,169
-273,589
| -94% | -$4.3M | ﹤0.01% | 3131 |
|
|
2021
Q4 | $5.15M | Buy |
289,758
+10,807
| +4% | +$324K | ﹤0.01% | 2358 |
|
|
2021
Q3 | $10.3M | Buy |
278,951
+994
| +0.4% | +$44.1K | ﹤0.01% | 2118 |
|
|
2021
Q2 | $16.5M | Sell |
277,957
-165
| -0.1% | -$10K | ﹤0.01% | 1912 |
|
|
2021
Q1 | $18.6M | Sell |
278,122
-4,207
| -1% | -$329K | ﹤0.01% | 1831 |
|
|
2020
Q4 | $17.1M | Sell |
282,329
-3,874
| -1% | -$264K | ﹤0.01% | 1780 |
|
|
2020
Q3 | $22.6M | Sell |
286,203
-12,115
| -4% | -$966K | ﹤0.01% | 1507 |
|
|
2020
Q2 | $18.6M | Sell |
298,318
-35,002
| -11% | -$2.04M | ﹤0.01% | 1579 |
|
|
2020
Q1 | $17.7M | Sell |
333,320
-20,230
| -6% | -$2.01M | ﹤0.01% | 1456 |
|
|
2019
Q4 | $42.8M | Sell |
353,550
-18,869
| -5% | -$2.71M | ﹤0.01% | 1273 |
|
|
2019
Q3 | $67.6M | Sell |
372,419
-25,582
| -6% | -$3.61M | 0.01% | 1040 |
|
|
2019
Q2 | $51.7M | Buy |
398,001
+34,437
| +9% | +$6.17M | 0.01% | 1198 |
|
|
2019
Q1 | $88.5M | Buy |
363,564
+1,797
| +0.5% | +$475K | 0.01% | 955 |
|
|
2018
Q4 | $68.9M | Buy |
361,767
+120,767
| +50% | +$29.5M | 0.01% | 1013 |
|
|
2018
Q3 | $79M | Buy |
241,000
+30,860
| +15% | +$9.45M | 0.01% | 1054 |
|
|
2018
Q2 | $65.6M | Sell |
210,140
-176,275
| -46% | -$53.8M | 0.01% | 1150 |
|
|
2018
Q1 | $94.1M | Sell |
386,415
-74,962
| -16% | -$21M | 0.01% | 1012 |
|
|
2017
Q4 | $139M | Sell |
461,377
-122,660
| -21% | -$34.1M | 0.02% | 848 |
|
|
2017
Q3 | $154M | Buy |
584,037
+56,408
| +11% | +$16.3M | 0.02% | 781 |
|
|
2017
Q2 | $139M | Sell |
527,629
-59,176
| -10% | -$14.8M | 0.02% | 822 |
|
|
2017
Q1 | $211M | Sell |
586,805
-2,936
| -0.5% | -$909K | 0.03% | 670 |
|
|
2016
Q4 | $170M | Buy |
589,741
+264
| +0% | +$81.8K | 0.02% | 753 |
|
|
2016
Q3 | $201M | Buy |
589,477
+686
| +0.1% | +$251K | 0.03% | 666 |
|
|
2016
Q2 | $250M | Buy |
588,791
+640
| +0.1% | +$264K | 0.03% | 569 |
|
|
2016
Q1 | $188M | Buy |
588,151
+54,627
| +10% | +$18.6M | 0.03% | 681 |
|
|
2015
Q4 | $277M | Buy |
533,524
+80,206
| +18% | +$29.6M | 0.04% | 519 |
|
|
2015
Q3 | $133M | Buy |
453,318
+47,872
| +12% | +$17M | 0.02% | 832 |
|
|
2015
Q2 | $159M | Sell |
405,446
-35,062
| -8% | -$12.4M | 0.02% | 811 |
|
|
2015
Q1 | $133M | Buy |
440,508
+47,707
| +12% | +$11.6M | 0.02% | 899 |
|
|
2014
Q4 | $87.4M | Buy |
392,801
+11,156
| +3% | +$2.3M | 0.01% | 1067 |
|
|
2014
Q3 | $88.5M | Buy |
381,645
+47,764
| +14% | +$12M | 0.01% | 1030 |
|
|
2014
Q2 | $73.8M | Buy |
333,881
+38,463
| +13% | +$8.56M | 0.01% | 1168 |
|
|
2014
Q1 | $93.2M | Buy |
295,418
+105,642
| +56% | +$33.6M | 0.01% | 1024 |
|
|
2013
Q4 | $49.4M | Sell |
189,776
-11,610
| -6% | -$2.54M | 0.01% | 1326 |
|
|
2013
Q3 | $29.5M | Sell |
201,386
-1,046
| -0.5% | -$126K | ﹤0.01% | 1538 |
|
|
2013
Q2 | $30.7M | Buy |
+202,432
| New | +$27.7M | 0.01% | 1473 |
|
Other funds holding TXMD
RCMNY
CC
SCM
VCM
TC
ACM
Fidelity Investments's TXMD Position: Q1 2026 in Review
Fidelity Investments reduced its TherapeuticsMD (TXMD) stake by 99% in Q1 2026, selling an estimated $18.5K and leaving 51 shares worth $103. The position accounts for ﹤0.01% of the portfolio, ranked #5261.
Fidelity Investments first reported a position in TXMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $277M in Q4 2015. 49 funds tracked by Wall St. Rank hold TXMD as of Q1 2026.
- Fidelity Investments held 51 shares of TherapeuticsMD worth $103 as of Q1 2026.
- Fidelity Investments sold 8,239 TherapeuticsMD shares in Q1 2026, an estimated $18.5K.
- TherapeuticsMD made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #5261 holding.
- Fidelity Investments first reported a position in TherapeuticsMD in Q2 2013 and has held it in 52 quarters since.
- Fidelity Investments's TherapeuticsMD position peaked at $277M in Q4 2015.
- 49 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.